| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1K | — |
| SG&A Expense | $2.4M | -78.7% |
| Operating Income | -$2.7M | -126.5% |
| Net Income | -$4.2M | -161.4% |
| EPS (Basic) | -$0.03 | — |
| EPS (Diluted) | -$0.03 | -142.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3K | -99.8% |
| Current Assets | $2.4M | -97.9% |
| Total Assets | $8.9M | -95.6% |
| Current Liabilities | $5.8M | -96.0% |
| Long-term Debt | $333K | — |
| Total Liabilities | $8.1M | -95.3% |
| Stockholders' Equity | $743K | -77.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.5M | +105.6% |
| Investing Cash Flow | -$5.5M | +93.8% |
| Financing Cash Flow | $3.0M | -93.4% |